Chronic effects of cannabis use on the auditory mismatch negativity

Biological Psychiatry

Volumn 75, Issue 6, 2014, Pages 449-458

  Greenwood, Lisa Marie ^a   Broyd, Samantha J ^a   Croft, Rodney ^a   Todd, Juanita ^b,c   Michie, Patricia T ^b,c   Johnstone, Stuart ^a   Murray, Robin ^d   Solowij, Nadia ^a,c  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cannabis; event related potentials; mismatch negativity; MMN; schizophrenia; sensory memory

Indexed keywords

CANNABIS; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADOLESCENT; ADULT; CANNABIS ADDICTION; CASE CONTROL STUDY; CHRONIC DISEASE; DRUG EFFECTS; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SCHIZOPHRENIA; SYMPTOM ASSESSMENT; SYNAPTIC TRANSMISSION; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; CANNABIS; CASE-CONTROL STUDIES; CHRONIC DISEASE; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SYMPTOM ASSESSMENT; SYNAPTIC TRANSMISSION; TIME FACTORS; YOUNG ADULT;

EID: 84894451421     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.05.035     Document Type: Article

References (103)

1. L. Degenhardt, and W. Hall Extent of illicit drug use and dependence, and their contribution to the global burden of disease Lancet 379 2012 55 70
2. C. Henquet, L. Krabbendam, J. Spauwen, C. Kaplan, R. Lieb, and H.U. Wittchen et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people BMJ 330 2005 11 14
3. R. Kuepper, J. van Os, R. Lieb, H.-U. Wittchen, M. Hoefler, and C. Henquet Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study BMJ 342 2011 d738
4. S. Zammit, P. Allebeck, S. Andreasson, I. Lundberg, and G. Lewis Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study BMJ 325 2002 1199 1201
5. M. Di Forti, C. Iyegbe, H. Sallis, A. Kolliakou, M.A. Falcone, and A. Paparelli et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users Biol Psychiatry 72 2012 811 816
6. R. van Winkel Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis Arch Gen Psychiatry 68 2011 148 157
7. S. Zammit, G. Spurlock, H. Williams, N. Norton, N. Williams, and M.C. O'Donovan et al. Genotype effects of CHRNA7, CNRI and COMT in schizophrenia: Interactions with tobacco and cannabis use Br J Psychiatry 191 2007 402 407
8. D.C. D'Souza, R.A. Sewell, and M. Ranganathan Cannabis and psychosis/schizophrenia: Human studies Eur Arch Psychiatry Clin Neurosci 259 2009 413 431
9. C. Henquet, M. Di Forti, P.D. Morrison, R. Kuepper, and R. Murray Gene-environment interplay between cannabis and psychosis Schizophr Bull 34 2008 1111 1121
10. R.M. Murray, P.D. Morrison, C. Henquet, and M. Di Forti Cannabis, the mind and society: the hash realities Nat Rev Neurosci 8 2007 885 895
11. T.H.M. Moore, S. Zammit, A. Lingford-Hughes, T.R.E. Barnes, P.B. Jones, and M. Burke et al. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review Lancet 370 2007 319 328
12. D.M. Semple, A.M. McIntosh, and S.M. Lawrie Cannabis as a risk factor for psychosis: Systematic review J Psychopharmacol (Oxf) 19 2005 187 194
13. M. Weiser, and S. Noy Interpreting the association between cannabis use and increased risk for schizophrenia Dialogues Clin Neurosci 7 2005 81 85
14. R.G. Pertwee The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin Br J Pharmacol 153 2008 199 215
15. R. Kuepper, P.D. Morrison, J. van Os, R.M. Murray, G. Kenis, and C. Henquet Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines Schizophr Res 121 2010 107 117
16. S. Bhattacharyya, J.A. Crippa, R. Martin-Santos, T. Winton-Brown, and P. Fusar-Poli Imaging the neural effects of cannabinoids: Current status and future opportunities for psychopharmacology Curr Pharm Des 15 2009 2603 2614
17. M.G. Bossong, B.N.M. van Berckel, R. Boellaard, L. Zuurman, R.C. Schuit, and A.D. Windhorst et al. Delta 9-Tetrahydrocannabinol induces dopamine release in the human striatum Neuropsychopharmacology 34 2009 759 766
18. N. Fan, H. Yang, J. Zhang, and C. Chen Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Δ9-THC exposure-impaired hippocampal synaptic plasticity J Neurochem 112 2010 691 702
19. R.E. Hampson, F. Miller, G. Palchik, and S.A. Deadwyler Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity Neuropharmacology 60 2011 944 952
20. B.D. Heifets, and P.E. Castillo Endocannabinoid signalling and long-term synaptic plasticity Annu Rev Physiol 71 2009 283 306
21. A.F. Hoffman, M. Oz, R. Yang, A.H. Lichtman, and C.R. Lupica Opposing actions of Δ9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation Learn Mem 14 2007 63 74
22. D.C. Javitt, D. Schoepp, P.W. Kalivas, N.D. Volkow, C. Zarate, and K. Merchant et al. Translating glutamate: From pathophysiology to treatment Sci Transl Med 3 2011 102mr2
23. M. Cohen, N. Solowij, and V. Carr Cannabis, cannabinoids and schizophrenia: Integration of the evidence Aust N Z J Psychiatry 42 2008 357 368
24. N. Solowij, and P.T. Michie Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci 32 2007 30 52
25. N. Solowij, and N. Pesa Cognitive abnormalities and cannabis use Rev Bras Psiquiatr 32 2010 S31 S40
26. M. Yücel, N. Solowij, C. Respondek, S. Whittle, A. Fornito, and C. Pantelis et al. Regional brain abnormalities associated with long-term heavy cannabis use Arch Gen Psychiatry 65 2008 694 701
27. R. Näätänen, and S. Kähkonen Central audtitory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: A review Int J Neuropsychopharmacol 12 2009 125 135
28. D. Umbricht, and S. Krljes Mismatch negativity in schizophrenia: A meta-analysis Schizophr Res 76 2005 1 23
29. M.I. Garrido, J.M. Kilner, K.E. Stephan, and K.J. Friston The mismatch negativity: A review of underlying mechanisms Clin Neurophysiol 120 2009 453 463
30. R.S. Ehrlichman, C.R. Maxwell, S. Majumdar, and S.J. Siegel Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice J Cogn Neurosci 20 2008 1403 1414
31. K. Heekeren, J. Daumann, A. Neukirch, C. Stock, W. Kawohl, and C. Norra et al. Mismatch negativity generation in the human 5HT(2A) agonist and NMDA antagonist model of psychosis Psychopharmacology (Berl) 199 2008 77 88
32. D. Umbricht, R. Koller, F.X. Vollenweider, and L. Schmid Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers Biol Psychiatry 51 2002 400 406
33. D. Umbricht, L. Schmid, R. Koller, F.X. Vollenweider, D. Hell, and D.C. Javitt Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: Implications for models of cognitive deficits in schizophrenia Arch Gen Psychiatry 57 2000 1139 1147
34. J.H. Krystal, E.B. Perry, R. Gueorguieva, A. Belger, S.H. Madonick, and A. Abi-Dargham et al. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function Arch Gen Psychiatry 62 2005 985 995
35. S. Leung, R.J. Croft, T. Baldeweg, and P.J. Nathan Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects Psychopharmacology (Berl) 194 2007 443 451
36. R. Näätänen The mismatch negativity: A powerful tool for cognitive neuroscience Ear Hear 16 1995 6 18
37. S. Grossberg, and M. Versace Spikes, synchrony, and attentive learning by laminar thalamocortical circuits Brain Res 1218 2008 278 314
38. R. Näätänen, T. Kujala, K. Kreegipuu, S. Carlson, C. Escera, and T. Baldeweg et al. The mismatch negativity: An index of cognitive decline in neuropsychiatric and neurological disease and in aging Brain 134 2011 3435 3453
39. R.J. Atkinson, P.T. Michie, and U. Schall Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis Biol Psychiatry 71 2012 98 104
40. M. Bodatsch, S. Ruhrmann, M. Wagner, R. Müller, F. Schultze-Lutte, and I. Frommann et al. Prediction of psychosis by mismatch negativity Biol Psychiatry 69 2011 959 966
41. M. Shaikh, L. Valmaggia, M.R. Broome, A. Dutt, J. Lappin, and F. Day et al. Reduced mismatch negativity predates the onset of psychosis Schizophr Res 134 2012 42 48
42. T. Friedman, P. Sehatpour, E. Dias, M. Perrin, and D.C. Javitt Differential relationships of mismatch negativity and visual P1 deficits to premorbid characteristics and functional outcome in schizophrenia Biol Psychiatry 71 2012 521 529
43. J. Todd, P.T. Michie, U. Schall, F. Karayanidis, H. Yabe, and R. Naatanen Deviant matters: Duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia Biol Psychiatry 63 2008 58 64
44. D.C. Javitt, A.M. Shelley, G. Silipo, and J.A. Lieberman Deficits in auditory and visual contextdependent processing in schizophrenia: Defining the pattern Arch Gen Psychiatry 57 2000 1131 1137
45. P.T. Michie What has MMN revealed about the auditory system in schizophrenia Int J Psychophysiol 42 2001 177 194
46. D. Umbricht, J.A. Bates, J.A. Lieberman, J.M. Kane, and D.C. Javitt Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia Biol Psychiatry 59 2006 762 772
47. P.E. Rasser, U. Schall, J. Todd, P.T. Michie, P.B. Ward, and P. Johnston et al. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia Schizophr Bull 37 2011 131 140
48. D.F. Salisbury, N. Kuroki, K. Kasai, M.E. Shenton, and R.W. McCarley Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia Arch Gen Psychiatry 64 2007 521 529
49. P. Roser, B. Della, C. Norra, I. Uhl, M. Bruene, and G. Juckel Auditory mismatch negativity deficits in long-term heavy cannabis users Eur Arch Psychiatry Clin Neurosci 260 2010 491 498
50. G. Juckel, P. Roser, T. Nadulski, A.M. Stadelmann, and J. Gallinat Acute effects of Delta(9)- tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity Schizophr Res 97 2007 109 117
51. F.M. Leweke, D. Piomelli, F. Pahlisch, D. Muhl, C.W. Gerth, and C. Hoyer et al. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia Transl Psychiatry 2 2012 e94
52. P. Roser, A.M. Stadelmann, L. Arning, J. Gallinat, J.T. Epplen, and G. Juckel Acute effects of Δ9-tetrahydrocannabinol on the auditory event-related mismatch negativity depending on genetic variations in the dysbindin, neuregulin and G72 gene Int J Neuropsychopharmacol 11 2008 256
53. J. Rentzsch, E. Buntebart, A. Stalelmeier, J. Gallinat, and M.C. Jockers-Scheruebl Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects Schizophr Res 130 2011 222 227
54. P. Roser, I.S. Haussleiter, H.-J. Chong, C. Maier, W. Kawohl, and C. Norra et al. Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia Psychopharmacology (Berl) 218 2011 611 620
55. N. Pesa, D.F. Hermens, R.A. Battisti, M. Kaur, I.B. Hickie, and N. Solowij Delayed preattentional functioning in early psychosis patients with cannabis use Psychopharmacology (Berl) 222 2012 507 518
56. J.B. Saunders, O.G. Aasland, T.F. Babor, J.R. de la Fuente, and M. Grant Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II Addiction 88 1993 791 804
57. D. Wechsler Wechsler Abbreviated Scale of Intelligence (WASI) 1999 Harcourt Assessment San Antonio, TX
58. N. Stefanis, M. Hanssen, N. Smirnis, D. Avramopoulos, I. Evdokimidis, and C. Stefanis et al. Evidence that three dimensions of psychosis have a distribution in the general population Psychol Med 32 2002 347 358
59. A. Raine The SPQ: A scale for the assessment of schizotypal personality based on DSM-III-R criteria Schizophr Bull 17 1991 555 564
60. A.T. Beck, R.A. Steer, and G.K. Brown Manual for the Beck Depression Inventory-II 1996 Psychological Corporation San Antonio, TX
61. C.D. Spielberger State-Trait Anxiety Inventory: A Comprehensive Bibliography 1989 Consulting Psychologists Press Palo Alto, CA
62. G. Andrews, and T. Slade Interpreting scores on the Kessler Psychological Distress Scale (K10) Aust N Z J Public Health 25 2001 494 497
63. A.J. Budney, J.R. Hughes, B.A. Moore, and R.G. Vandrey A review of the validity and significance of the cannabis withdrawal syndrome Am J Psychiatry 161 2004 1967 1977
64. E. Barkus, J. Stirling, R. Hopkins, and S. Lewis Cannabis-induced psychosis-like experiences are associated with high schizotypy Psychopathology 39 2006 175 178
65. T. Kujala, M. Tervaniemi, and E. Schröger The mismatch negativity in cognitive and clinical neuroscience: Theoretical and methodological considerations Biol Psychol 74 2007 1 19
66. C.C. Duncan, R.J. Barry, J.F. Connolly, C. Fischer, P.T. Michie, and R. Näätänen et al. Event-related potentials in clinical research: Guidelines for eliciting, recording and quantifying mismatch negativity, P300, and N400 Clin Neurophysiol 120 2009 1883 1908
67. N. Solowij, M. Yücel, V. Lorenzetti, and D.I. Lubman Does Cannabis cause lasting brain damage? D. Castle, R.M. Murray, D.C. D'Souza, Marijuana and Madness 2nd ed 2012 Cambridge University Press Cambridge 103 113
68. R. Näätänen, T. Kujala, C. Escera, T. Baldeweg, K. Kreegipuu, and S. Carlson et al. The mismatch negativity (MMN) - a unique window to disturbed central auditory processing in ageing and different clinical conditions Clin Neurophysiol 123 2012 424 458
69. M. Rais, W. Cahn, N.V. Haren, H. Schnack, and E. Caspers Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients Am J Psychiatry 165 2008 490 496
70. M. Rais, N. Van Haren, W. Cahn, H. Schnack, H. Hulshoff Pol, and R. Kahn Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia Schizophr Res 117 2010 172
71. I. Mataa, R. Perez-Iglesiasa, R. Roiz-Santiañeza, D. Tordesillas-Gutierreza, A. Pazosb, and A. Gutierrezc et al. Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use Brain Res 1317 2010 297 304
72. C. Arango, M. Rapado-Castro, S. Reig, J. Castro-Fornieles, A. González-Pinto, and S. Otero et al. Progressive brain changes in children and adolescents with first-episode psyhcosis Arch Gen Psychiatry 69 2012 16 26
73. G. Douaud, C. Mackay, J. Andersson, S. James, D. Quested, and M. Kar Ray et al. Schizophrenia delays and alters maturation of the brain in adolescence Brain 132 2009 2437 2448
74. L. Palaniyappan, P. Mallikarjun, V. Joseph, T.P. White, and P.F. Liddle Folding of the prefrontal cortex in schizophrenia: Regional differences in gyrification Biol Psychiatry 69 2011 974 979
75. D. Sun, G.W. Stuart, M. Jenkinson, S.J. Wood, P.D. McGorry, and D. Velakoulis et al. Brain surface contraction mapped in first-episode schizophrenia: A longitudinal magnetic resonance imaging study Mol Psychiatry 14 2009 976 986
76. N. Solowij, M. Yücel, C. Respondek, S. Whittle, E. Lindsay, and C. Pantelis et al. Cerebellar whitematter changes in cannabis users with and without schizophrenia Psychol Med 41 2011 2349 2359
77. T.M. Talavage, M.I. Sereno, J.R. Melcher, P.J. Ledden, B.R. Rosen, and A.M. Dale Tonotopic organization in human auditory cortex revealed by progressions of frequency sensitivity J Neurophysiol 91 2004 1282 1296
78. J. He Long-latency neurons in auditory cortex involved in temporal integration: Theoretical analysis of experimental data Hear Res 121 1998 147 160
79. J. He, T. Hashikawa, H. Ojima, and Y. Kinouchi Temporal integration and duration tuning in the dorsal zone of cat auditory cortex J Neurosci 17 1997 2615 2625
80. P.T. Michie, T.W. Budd, J. Todd, D. Rock, H. Wichmann, and J. Box et al. Duration and frequency mismatch negativity in schizophrenia Clin Neurophysiol 111 2000 1054 1065
81. J. Todd, P.T. Michie, U. Schall, P.B. Ward, and S.V. Catts Mismatch negativity (MMN) reduction in schizophrenia-impaired prediction - error generation, estimation or salience? Int J Psychophysiol 83 2012 222 231
82. T. Rosburg, P. Trautner, E. Ludowig, C. Schaller, M. Kurthen, and C.E. Elger et al. Hippocampal event related potentials to tone duration deviance in a passive oddball paradigm in humans Neuroimage 37 2007 274 281
83. A. Zalesky, N. Solowij, M. Yücel, D.I. Lubman, M. Takagi, and I.H. Harding et al. Effect of long-term cannabis use on axonal fibre connectivity Brain 135 2012 2245 2255
84. I.H. Harding, N. Solowij, B.J. Harrison, M. Takag, V. Lorenzetti, and D.I. Lubman et al. Functional connectivity in brain networks underlying cognitive control in chronic cannabis users Neuropsychopharmacology 37 2012 1923 1933
85. L. Sokolic, L.E. Long, G.E. Hunt, J.C. Arnold, and I.S. McGregor Disruptive effects of the prototypical cannabinoid Δ9-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats Behav Pharmacol 22 2011 191 202
86. J. Baek, Y. Zheng, C.L. Darlington, and P.F. Smith Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei Acta Otolaryngol 128 2008 961 967
87. O. Whitney, K. Soderstrom, and F. Johnson CB1 cannabinoid receptor activation inhibits a neural correlate of song recognition in an auditory/perceptual region of the zebra finch telencephalon J Neurobiol 56 2003 266 274
88. D.H. Chi, and K. Kandler Cannabinoid receptor expression at the MNTB-LSO synapse in developing rats Neurosci Lett 509 2012 96 100
89. K. Soderstrom, and Q. Tian CB1 cannabinoid receptor activation dose dependently modulates neuronal activity within caudal but not rostral song control regions of adult zebra finch telencephalon Psychopharmacology (Berl) 199 2008 265 273
90. Y. Zhao, M.E. Rubio, and T. Tzounopoulos Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem J Neurophysiol 10 2009 2434 2446
91. D.C. Javitt, M. Steinschneider, C.E. Schroeder, and J.C. Arezzo Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: Implications for schizophrenia PNAS 93 1996 11962 11967
92. M. Sedlacek, P.W. Tipton, and S.D. Brenowitz Sustained firing of cartwheel cells in the dorsal cochlear nucleus evokes endocannabinoid release and retrograde suppression of parallel fiber synapses J Neurosci 31 2011 15807 15817
93. Y. Zhao, M. Rubio, and T. Tzounopoulos Mechanisms underlying input-specific expression of endocannabinoid-mediated synaptic plasticity in the dorsal cochlear nucleus Hear Res 279 2011 67 73
94. T. Baldeweg, A. Klugman, J. Gruzelier, and S.R. Hirsch Mismatch negativity potentials and cognitive impairment in schizophrenia Schizophr Res 69 2004 203 217
95. C. O'Donnell, and M.F. Nolan Tuning of synaptic responses: An organizing principle for optimization of neural circuits TINS 34 2011 51 60
96. E. Keimpema, K. Mackie, and T. Harkany Molecular model of cannabis sensitivity in developing neuronal circuits Trends Pharmacol Sci 32 2011 551 561
97. J. Hirvonen, R.S. Goodwin, C.-T. Li, G.E. Terry, S.S. Zoghbi, and C. Morse et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers Mol Psychiatry 17 2012 642 649
98. A. Higuera-Matas, M. Miguens, S.M. Coria, M. Amparo Assis, E. Borcel, and N. del Olmo et al. Sex-specific disturbances of the glutamate/GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure Neuropharmacology 62 2012 1975 1984
99. E. Puighermanal, G. Marsicano, A. Busquets-Garcia, B. Lutz, R. Maldonado, and A. Ozaita Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling Nat Neurosci 12 2009 1152 1160
100. T. Rubino, N. Realini, D. Braida, S. Guidi, V. Capurro, and D. Vigano et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood Hippocampus 19 2009 763 772
101. J.M. Stone, O. Howes, A. Egerton, J. Kambeitz, P. Allen, and D. Lythgoe et al. Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis Schizophr Res 68 2010 599 602
102. J.M. Stone, E. Bramon, A. Pauls, A. Sumichb, and P.K. McGuire Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials Psychiatry Res 183 2010 174 176
103. G.A. Light, and D.L. Braff Mismatch negativity deficits are associated with poor functioning in schizophrenia patients Arch Gen Psychiatry 62 2005 127 136